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Abstract— The use of therapeutic ultrasound delivered via 
small diameter wire waveguides may represent an emerging 
minimally invasive approach in the treatment of chronic total 
occlusions (CTOs), calcified and fibrous plaques. The distal-tip 
mechanical vibrations (typically 0-210 µm peak-to-peak) have 
been reported to debulk rigid calcified and fibrous tissues while 
healthy elastic arterial tissue remains largely unaffected. The 
risk of arterial (healthy tissue) perforation with energized 
waveguides is not fully understood. An ultrasonic apparatus 
capable of delivering a range of wire waveguide distal-tip 
displacements, up to 80 µm peak-to-peak (p-p), at an 
operational frequency of 22.5 KHz (+/- 6%) has been developed. 
For three distal-tip displacement settings (32, 50 and 80 µm p-p) 
with 1.0 mm diameter waveguides, the force required to 
perforate healthy porcine aortic tissue was experimentally 
determined.  
The results show a distinct two stage perforation, thought to 
be the result of different mechanical properties of the layers in 
the arterial wall. The average maximum force (N) required to 
cause perforation with the 1.0 mm diameter ultrasonic 
waveguide activated at the three settings was experimentally 
determined to be 2.7 N (32 µm p-p), 2.6 N (50 µm p-p) and 2 N 
(80 µm p-p). The force required to cause perforation of the 
tissue with no ultrasound was found to be approximately 4 N. 
These results highlight that when ultrasound energy is applied 
to the waveguide, less force is required to perforate healthy 
arterial tissue. This reduction in perforation force is more 
pronounced at higher ultrasonic displacements, similar to those 
reported in clinical studies for the effective removal of diseased 
calcified and fibrous plaques.   
I. INTRODUCTION 
ardiovascular diseases (CVDs) are the number one 
cause of death globally [1]. Atherosclerosis is an intimal 
lesion that effects large and medium sized muscular arteries 
(such as coronary, iliac and femoral) and also large elastic 
arteries (such as aorta). It is a gradual chronic cardiovascular 
disease and is the most common cause of acute myocardial 
infarction [2], [3]. 
 This disease begins with deposits of fatty substances 
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(lipoproteins), cholesterol and cellular waste on the arterial 
endothelium but may progress to a fibro-calcific plaque. The 
majority of atherosclerotic lesions can be treated by 
minimally invasive dilation procedures such as balloon 
angioplasty and stent implantation.  
 These procedures often require that the lesion is initially 
crossed by a guidewire, a thin wire that acts as a rail for the 
dilation catheter. Plaques resulting in a near or totally 
occluded artery are known as chronic total occlusions 
(CTOs) and are often associated with dense calcifications. 
They can be identified in approximately 20% of all patients 
undergoing angioplasty and are challenging to classic 
dilation procedures that require prior guidewire crossing [4]. 
The limitations of standard dilation procedures mentioned 
have propagated an intensive search for adjuncts to balloon 
angioplasty and alternative therapies [5]-[8].  
One such approach involves the use of low frequency (20-
45 kHz) high power therapeutic ultrasonic energy delivered 
via small diameter wire waveguides. This form of energy 
develops a longitudinal standing wave in the wire waveguide 
and can result in distal-tip displacements up to 210µm peak-
peak (p-p). This type of minimally invasive surgery has 
gained regulatory approval in recent years (2007/8) in the 
United States and Europe for treatment of CTOs [9]. It is 
reported that this form of energy can be useful for the 
treatment of CTOs by disrupting and ablating rigid calcified 
and fibrous plaque tissue while the healthy elastic arterial 
tissue in the region remains largely unaffected [10].   
Using ultrasound in this manner may affect plaque by a 
number of ablation or disruption mechanisms. Direct 
mechanical agitation, cavitation, acoustic streaming and 
pressure components have all been reported [11], [12].  
While the effects of ultrasound on rigid calcified and 
fibrous tissues have been the focus of the majority of studies 
the impact that this form of energy delivery has on 
surrounding healthy tissue is less well known, including 
adverse effects such as the risk of arterial perforation. 
Chikada [13] conducted a number of experiments on 
diseased and healthy tissue using a 2.5 mm probe at an 
operational frequency of 24 kHz. This study focused on the 
ablation and removal of diseased plaques and demonstrated 
incidents of perforation of the surrounding healthy tissue at 
greater distal-tip displacements. The forces required to 
perforate the various plaque types were not reported while 
probe dimensions and amplitudes were not representative of 
minimally invasive ultrasonic angioplasty devices. 
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As part of this work, the goal was to experimentally 
determine the forces required to perforate healthy porcine 
aortic tissue using waveguide distal-tip geometries and 
displacements similar to those reported in clinical studies 
[9]-[13]. 
II. METHODOLOGY 
A. Ultrasonic Wire Waveguide Apparatus 
An experimental ultrasonic apparatus was developed that 
can transmit ultrasonic energy through 1.0 mm diameter 
Nickel-Titanium (NiTi) waveguides with rounded distal tips. 
The frequency of operation was experimentally determined, 
as part of previous work, to be 22.5 KHz (+/- 6%) with 
achievable distal tip displacements of between 0 - 100µm p-
p depending on power input level [14],[15]. These ultrasonic 
displacement measurements were made with an optical 
microscope and vision analysis software. 
 
B. Experimental Rig Development 
A test rig capable of advancing the ultrasonic waveguide 
vertically in a controlled manner was designed and 
developed. The ultrasonic converter and acoustic horn were 
secured vertically to a stepper motor lead screw assembly. 
The waveguide could be advanced at constant feed-rates 
between 0.05 and 1.5 mm/s, controlled via a stepper drive 
card. 
The rig facilitated the securing of tissue samples in a 
cantilever beam assembly which had a half-bridge 
temperature compensation strain gauge arrangement capable 
of determining the force applied on the sample. The beam 
and tissue were submerged in a 15 L thermostatic bath of 
water at 37 0C.  The programming environment and 
hardware used to control the various instruments and 
acquisition of data was LabView© and National 
Instruments© PCI6221 DAQ. A schematic of the 
experimental set up is shown below, see Figure 1. 
 
Fig. 1.  Schematic of experimental rig with ultrasonic angioplasty 




Fig. 2.  Picture of experimental rig for tissue testing using ultrasound 




Fig. 3. Picture of cantilever beam tissue holder and strain gauge 
arrangement. 
 
C. Tissue Preparation 
Approximately 150 mm length of porcine aortic tissue was 
harvested, refrigerated and prepared for testing less than 24 
hours after death. A single aortic section was cut into twelve 
sample sizes of 5 mm × 20 mm. Connective tissue was also 
removed from arteries outer wall. The tissue was stored in a 
saline solution at 370C for approximately one hour prior to 
testing.  
 
D. Experimental Protocol 
To test the force required to perforate the arterial tissue in 
vitro, the 1.0 mm diameter waveguide was advanced through 
the samples (at 370C) both with and without ultrasonic 
activation. All experiments were conducted with a constant 
feed-rate of 0.5 mm/s.  
For the experiments with ultrasonic waveguide activation 
the ultrasound was operated in continuous mode at 22.5 kHz. 
  
Three different power settings were tested corresponding to 
distal-tip displacements of 32, 50 and 80 µm p-p. 
III. RESULTS AND DISCUSSION 
A total of 12 porcine aorta tissue samples were tested. 
Three samples were subjected to perforation with no 
ultrasonic energy applied to the waveguide and nine samples 
(three per power setting level) with the ultrasonic activation. 
Figure 4 shows examples of the experimental perforation 
profiles achieved for the waveguide with no ultrasound 
activation and for the three power settings. The results show 
a two stage penetration, both with and without ultrasound. 
This may be associated with the composition of the aortic 
lumen, namely the two structural layers of varying elasticity 
(intima-media and adventitia).  
 
The curves may be described as follows: 
a) An initial rise in force as the wire wave-guide 
contacts the sample. 
b) Peak 1: This initial maximum peak force is thought 
to represent perforation of the intima-media layer 
(samples were set-up so the internal arterial wall 
was penetrated, simulating the in vivo scenario).  
c) A secondary rise in force as the waveguide contacts 
the adventitia layer. 
d) Peak 2: Perforation of the adventitia layer and an 
associated reduction in force to a negligible value. 
 
It is also possible to see that when the waveguide is not 
activated, there is a net reactive force on the waveguide after 
perforation due to friction with the tissue. This force appears 
to be less in the tests with the ultrasound applied. 
   
 
 Fig. 4.  Penetration force profiles, with no ultrasound applied (No US) 
 and for an ultrasonic wire waveguide distal-tip displacement of 32 µm 
peak-to-peak. Waveguide feed-rate = 0.5 mm/s. 
 
The increase in ultrasonic power to the wire waveguide 
and therefore increased distal-tip displacements resulted in a 
lower force required to perforate both the intima-media layer 
and the adventitia. The results of the maximum penetration 
force in all 12 experiments are shown in Figure 5.  
The average maximum force (Newtons) required for 
perforation with ultrasound is approximately 30% (3.96 N 
vs. 2.67 N) less than without ultrasound at the lowest 
ultrasonic power setting (32µm p-p). With no ultrasound 
activation, it was found that a force exceeding 3.8 N resulted 
in perforation of the healthy arterial tissue with the 1mm 
rounded waveguide distal-tip, while at ultrasonic energy 
levels of 80 µm p-p this was reduced to approximately 2 N. 
 
 
Fig. 5.  Maximum penetration force (through intima-media layer) with no 
ultrasound applied (No US) and for ultrasonic wire waveguide distal-tip 
displacement of 32, 50 and  80 µm peak-to-peak. All 12 tissue tests shown. 
Waveguide feed-rate = 0.5 mm/s.  
IV. CONCLUSIONS 
Chronic total occlusions are associated with increased 
complications, including incidence of arterial perforation due 
to their geometrical and mechanical composition. As a result, 
they often require more aggressive strategies. Therapeutic 
ultrasound angioplasty has been shown to be effective in the 
removal of fibrous and calcified plaques. Increases in distal-
tip displacements have also been shown to increase removal 
rates of the diseased tissues, particularly calcified plaques.   
This study indicates that at the displacements required to 
effectively remove diseased tissue, there may be an 
associated reduction in the force required to cause 
perforation of the healthy arterial wall. For the experiments 
outlined above, the angle of incidence of the waveguide is 90 
degrees and may not be entirely representative of the in vivo 
situation where lower contact angles are more probable from 
waveguide deflection off the lumen axis. Also, the diameter 
of wire used in this study is greater than those reported in the 
literature for arterial access and is, therefore, more rigid.  
Incidence of arterial perforation still occur, however, with 
highly flexible guidewires and devices and the results 
presented here show that with ultrasonic activation the force 
required to cause perforation may be reduced further.  
These results may prove useful in determining optimum 
operating powers for safe selective tissue removal, while 
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